CHRNA7 and major depressive disorder: For instance, Zhao et al. demonstrated that the treatment with α7 nAChR agonist DMXBA could reverse the chronic stress-induced increase in Tregs cells, thereby limiting the inflammatory response in the brain and attenuating the depression-like behavior in chronic restraint stress (CRS) mice [184].